nivolumab plus ipilimumab melanoma

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nivolumab plus ipilimumab melanoma	0.38	0.8	7425	51	34
nivolumab	1.48	0.6	7399	79	9
plus	1.26	0.6	6091	87	4
ipilimumab	0.59	0.1	5615	77	10
melanoma	0.47	0.7	9175	99	8

Keyword	CPC	PCC	Volume	Score
ipilimumab and nivolumab metastatic melanoma	0.1	0.9	9223	29
nivolumab plus ipilimumab with or without	0.21	0.2	7633	43
ipilimumab + nivolumab	0.74	0.6	7536	43
nice ipilimumab nivolumab melanoma	1.47	0.3	8321	81
nivolumab plus ipilimumab renal cancer	1.06	1	3590	93
nivolumab combined with ipilimumab	0.7	0.6	4062	36
ipilimumab and nivolumab patient information	1.77	0.3	9761	70
nivolumab ipilimumab lung cancer	1.71	0.3	3908	59
nivolumab and ipilimumab therapy	1.33	0.5	2323	9
ipilimumab nivolumab colon cancer	0.99	0.9	8237	43
nivolumab ipilimumab colorectal cancer	0.54	0.8	3777	40
combination of nivolumab and ipilimumab	0.14	0.1	1266	44
ipilimumab nivolumab metastatic melanoma	0.37	0.8	3657	1
nivolumab plus ipilimumab melanoma	0.79	1	5918	38
nivolumab for metastatic melanoma	0.07	0.7	9928	94
ipilimumab and nivolumab lung cancer	1.08	0.7	5929	26
what is ipilimumab and nivolumab	1.36	0.8	6016	50
ipilimumab and nivolumab immunotherapy	0.33	0.2	1824	96
nivolumab and ipilimumab mesothelioma	1.55	0.8	1223	81
ipilimumab and nivolumab macmillan	1.96	0.4	9490	94
ipilimumab and nivolumab regimen	1.44	1	1848	15
ipilimumab and nivolumab renal cell carcinoma	1.66	0.6	3619	100
nivolumab immunotherapy for melanoma	0.41	1	1335	91
nivolumab + ipilimumab	1.33	0.2	8676	69